Research Nester released a report titled “Acute Myeloid Leukemia (AML) Treatment Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global AML treatment market in terms of market segmentation by disease type, treatment type, end-user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global AML treatment market is estimated to grow at a significant CAGR during the forecast period, i.e., 2021-2029, primarily on account of the rising prevalence of acute myeloid leukemia cancers worldwide. In the United States, an estimated 19,500 new cases of AML occur every year, according to the statistics by the National Cancer Institute (NCI). The market is also thriving on account of the growing initiatives of the government to promote research and development to curb and control cancer mortality rate, and further to raise awareness for chronic diseases among individuals.
Request Report Sample@ https://www.researchnester.com/sample-request-2894
The market is segmented on the basis of treatment type into chemotherapy, stem cell transplantation, anticancer drugs, and others, out of which, the chemotherapy segment is projected to register the largest market share in 2021, and is the most prominently used treatment method for cancer. Alternatively, the anticancer drugs segment, which is anticipated to hold a modest share in the year 2021, is specifically used for rare cases of leukemia cell mutations. The market is further segmented by disease type into promyelocytic, myeloblastic, myelomonocytic, monocytic and others. On the basis of end-user, the market is segmented into hospitals, specialty clinics and others.
Based on geographical analysis, the global AML treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America is anticipated to garner the largest share by the end of 2029 on the back of rising investment in medical R&D and the availability of an exceptional public health sector, followed by the reimbursement medical policies of the government. As of 2018, 16.416 % of the total GDP in North America was spent on the healthcare sector, as per the data by World Health Organization (WHO). In other statistics by the NCI, AML accounts for 1.8% of all cancer deaths in the U.S., as of 2020.
Rising Cases of AML Along with the Growing Need for Better Cancer Treatment Facilities to Boost the Market Growth
The rising prevalence of acute myeloid leukemia globally is estimated to act as the key growth factor for the AML treatment market. Moreover, growing need for advanced medicines and effective treatment methods are estimated to surge the demand for extensive research regarding AML treatment., and in turn drive the market growth. However inflated treatment cost and unavailability of the treatment in various developing economies are the major restraints for the market growth. Additionally, side effects associated with chemotherapy and stem cell transplant are some of the factors that may hinder the growth of the market.
This report also provides the existing competitive scenario of some of the key players of the global AML treatment market which includes company profiling of Novartis AG (NYSE: NVS), Pfizer Inc. (NYSE: PFE), and Johnson & Johnson Services Inc. (NYSE: JNJ). Apart from these major industry leaders in the market, the report also provides company profiling of the major companies involved in the research and development of AML treatment drugs that are undergoing different phases of clinical trials, including Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), Bristol Myers Squibb (NYSE: BMY), Sanofi-aventis Groupe (NASDAQ: SNY) and Eisai Co. Ltd. (OTCMKTS: ESALY) among others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global AML treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-2894
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info:
A J Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
